ESC 365 - Efficacy and safety of HDL/apoA-1 mimetics on human and mice with atherosclerosis: a systematic review and meta-analysis

ESC Premium Access

Efficacy and safety of HDL/apoA-1 mimetics on human and mice with atherosclerosis: a systematic review and meta-analysis

Session: ePosters

Topic: Pharmacotherapy

Speaker: Miss A. Abudukeremu (Guangzhou, CN)

Event: ESC Asia with APSC & AFC 2021

Congress Session

About the speaker

Miss Ayiguli Abudukeremu

Sun Yat-sen Memorial Hospital, Sun Yat-sen University South Campus Outpatient Clinic, Guangzhou (China)

0 follower

143 more presentations in this session

Instantaneous wave-free ratio and fractional flow reserve: effect of variation in left ventricular end diastolic pressure

Speaker: Doctor P. Sharma (Mangalore, IN)

Impact of SARS-CoV2 pandemic onto acute ST-elevation myocardial infarction care and patient outcomes in a large tertiary cardiac center.

Speaker: Doctor D. Yong (Kuala Lumpur, MY)

Coronary atherosclerotic burden and trimethylamine N-oxide in non-ST-segment myocardial infarction patients: SZ-NSTEMI cohort

Speaker: Doctor K. Bin Waleed (London, GB)

Pulmonary artery pulsatility index and hemolysis during Impella support

Speaker: Doctor M. Nakamura (Toyama, JP)

Relationship of mean platelet volume to severity of coronary atherosclerosis in non-ST-segment myocardial infarction

Speaker: Doctor K. Bin Waleed (London, GB)

Access the full session

ePosters

Speakers: Miss A. Abudukeremu, Doctor P. Sharma, Doctor D. Yong, Doctor K. Bin Waleed, Doctor M. Nakamura...

About the event

ESC Asia with APSC & AFC 2021

2 December - 4 December 2021

Sessions Presentations

Congress

Related content

ESC Premium Access

IAMI - Panel discussion.

30 August 2021

Open Access

Panel discussion and conclusion.

29 August 2021

ESC Premium Access

Cardiovascular protection by combination of the selective nonsteroidal MR antagonist finerenone and the SGLT2 inhibitor empagliflozin in a preclinical model of hypertension-induced end-organ damage

27 August 2021

This platform is supported by